Gene · 3838
Papers1,821
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,821
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis and experimental studies reveal KPNA2 as a novel biomarker of hepatocellular carcinoma progression and telomere maintenance. | Eur J Med Res | 2025 | 40665355 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers related to epithelial-mesenchymal transition and anoikis in hepatocellular carcinoma using transcriptomics and single-cell sequencing. | Front Cell Dev Biol | 2025 | 40612108 | PubTator, text mining | PubMed |
| Identification and validation of the fibrosis-related molecular subtypes of hepatocellular carcinoma by bioinformatics. | Discov Oncol | 2025 | 40549259 | PubTator, text mining | PubMed |
| tRF-5004b Enriched Secretory Autophagosomes Induce Endothelial Cell Activation to Drive Acute Respiratory Distress Syndrome. | Adv Sci (Weinh) | 2025 | 40539385 | PubTator, text mining | PubMed |
| Scaffolding Protein ENH Promotes Tumor Angiogenesis and Growth Through Macrophage Recruitment and Polarization. | Adv Sci (Weinh) | 2025 | 40536254 | PubTator, text mining | PubMed |
| Anoikis in hepatocellular carcinoma: genetic alterations and immune microenvironment insights from single-cell and computational analysis. | Discov Oncol | 2025 | 40447878 | PubTator, text mining | PubMed |
| Importin-alpha transports Norrin to the nucleus to promote proliferation and Notch signaling in glioblastoma stem cells. | Oncogene | 2025 | 40425833 | PubTator, text mining | PubMed |
| RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer. | Front Immunol | 2025 | 40370450 | PubTator, text mining | PubMed |
| circ-C20orf11 promotes karyopherin alpha 2 expression through miR-495-3p and affects non-small cell lung cancer development. | J Physiol Pharmacol | 2025 | 40350652 | PubTator, text mining | PubMed |
| FoxM1 promotes the proliferation of cervical adenocarcinoma cells through transcriptional activation of FAM83D. | Life Sci | 2025 | 40345484 | PubTator, text mining | PubMed |
| Multiple-omics analysis of aggrephagy-related cellular patterns and development of an aggrephagy-related signature for hepatocellular carcinoma. | World J Surg Oncol | 2025 | 40307857 | PubTator, text mining | PubMed |
| A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision. | Int J Biol Macromol | 2025 | 40306500 | PubTator, text mining | PubMed |
| USP7 promotes the malignant progression of osteosarcoma through the KPNA2/PKLR axis. | Cell Signal | 2025 | 40250695 | PubTator, text mining | PubMed |
| Targeting ferroptosis: a novel pathway in oral, oropharyngeal, hypopharyngeal, and laryngeal cancers. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 40227310 | PubTator, text mining | PubMed |
| KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1. | Oncogene | 2025 | 40216969 | PubTator, text mining | PubMed |
| Identification of telomere maintenance-driven molecular subtypes in hepatocellular carcinoma: implications for prognosis and targeted therapy via KPNA2. | Discov Oncol | 2025 | 40214910 | PubTator, text mining | PubMed |
| Prognostic markers and molecular pathways in primary colorectal cancer with a high potential of liver metastases: a systems biology approach. | Res Pharm Sci | 2025 | 40190820 | PubTator, text mining | PubMed |
| Artificial Intelligence-Empowered Automated Double Emulsion Droplet Library Generation. | Small | 2025 | 40130763 | PubTator, text mining | PubMed |
| Identification of CCNB1 as a biomarker for cellular senescence in hepatocellular carcinoma: a bioinformatics and experimental validation study. | Discov Oncol | 2025 | 40128499 | PubTator, text mining | PubMed |
| Immunohistochemical Characterization of Feline Giant Cell Tumor of Bone (GCTb): What We Know and What We Can Learn from the Human Counterpart. | Animals (Basel) | 2025 | 40075982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3838/papers?page=4